Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes
Get Live Data
1,903.50    -9.50 (-0.50%)
Bid:
1,904.00
Ask:
1,905.00
Spread: 1.00 (0.053%)
Market Cap: £76.34b
GSK Live PriceLast checked at - London Stock Exchange

Intraday Glaxosmithkline Share Chart

Glaxosmithkline News

LONDON MARKET CLOSE: Stocks rise amid trade de-escalation boost
16 May 2025

LONDON MARKET CLOSE: Stocks rise amid trade de-escalation boost

(Alliance News) - The FTSE 100 pushed higher on Friday, ending the week on a strong note, and now at the level it roughly stood at prior to US Preside...

London close: Stocks finish choppy week in the black
16 May 2025

London close: Stocks finish choppy week in the black

(Sharecast News) - London equities ended the week higher on Friday, supported by gains in pharmaceutical and energy stocks.

US House panel seeks information from Pfizer over alleged COVID vaccine delay
15 May 2025

US House panel seeks information from Pfizer over alleged COVID vaccine delay

House committee asks Pfizer for information on alleged comments that company delayed trial results of COVID-19 vaccine *

LONDON MARKET MIDDAY: FTSE 100 outperforms as Europe underwhelms
15 May 2025

LONDON MARKET MIDDAY: FTSE 100 outperforms as Europe underwhelms

(Alliance News) - London's FTSE 100 outperformed European peers, though a share price fall for oil majors and a host of other shares that went ex-divi...

How are vaccines tested?
14 May 2025

How are vaccines tested?

May 14 (Reuters) - U.S. Health and Human Services Secretary Robert F. Kennedy Jr. plans to require all new vaccines be tested against a placebo in h...

LONDON BROKER RATINGS: RBC cuts AB Foods; JPMorgan raises Mondi
14 May 2025

LONDON BROKER RATINGS: RBC cuts AB Foods; JPMorgan raises Mondi

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

GSK acquires "potential best-in-class" medicine efimosfermin
14 May 2025

GSK acquires "potential best-in-class" medicine efimosfermin

(Alliance News) - GSK announced on Wednesday that it has agreed with Boston Pharmaceuticals to buy steatotic liver disease medication efimosfermin alf...

FDA upheaval pushes some biotech firms to plan early trials out of US
14 May 2025

FDA upheaval pushes some biotech firms to plan early trials out of US

Biotechs fear changes at FDA could slow U.S. drug development *